Clindamycin phosphate

Drug ingredientActive Shortage

CAS 24729-96-2

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 24729-96-2
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

49 FDA-registered drug labelers
A-S Medication Solutions
ACS Dobfar S.p.A
Actavis Pharma, Inc.
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Amneal Pharmaceuticals NY LLC
Aurobindo Pharma Limited
Bausch Health US LLC
Baxter Healthcare Company
Baxter Healthcare Corporation
Bryant Ranch Prepack
Carnegie Pharmaceuticals, LLC
Chartwell RX, LLC
Chongqing Carelife Pharmaceutical Co Ltd.
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Encube Ethicals, Inc.
Galenova Inc
GLENMARK PHARMACEUTICALS INC., USA
Henry Schein, Inc.
Hubei Yitai Pharmaceutical Co., Ltd
i3 Pharmaceuticals, LLC
LETCO MEDICAL, LLC
Mayne Pharma
Medical Purchasing Solutions, LLC
Medimetriks Pharmaceuticals
Medimetriks Pharmaceuticals, Inc.
Medisca Inc.
Mylan Pharmaceuticals Inc.
NORTHSTAR RX LLC
Oceanside Pharmaceuticals
Organon LLC
Padagis Israel Pharmaceuticals Ltd
Pharmacia & Upjohn Company LLC
Preferred Pharmaceuticals Inc
Professional Compounding Centers of America
ProPharma Distribution
Rising Pharma Holdings, Inc.
Sagent Pharmaceuticals
Solaris Pharma Corporation
Sun Pharmaceutical Industries, Inc.
Taro Pharmaceuticals U.S.A., Inc.
Trifarma S.p.A
Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni
Viona Pharmaceuticals Inc
Xenex Laboratories Inc
Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.
Zhejiang Tiantai Pharmaceutical Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 24 drug and cosmetic product listings (FDA).

  • •Clindamycin
  • •Clindamycin Phosphate
  • •Clindamycin Phosphate AND Benzoyl Peroxide Clindamycin Phosphate AND Benzoyl Peroxide
  • •Clindamycin Phoaphate Topical Solution USP, 1%
  • •Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%
  • •Onexton
  • •Clindamycin Phoaphate Topical USP, 1%
  • •Clindamycin Phosphate and Benzoyl Peroxide
FDA Shortage Status
Active Shortage
Shortage History
  • Current shortage

    Clindamycin Phosphate Injection

    Shortage listed since March 21, 2023

    Manufacturer reports: 1 unavailable, 2 limited, 1 available

  • to be discontinued

    Clindamycin Phosphate; Benzoyl Peroxide Gel

    Shortage listed since August 1, 2025

See all current drug shortages

Chemical Identity

CAS24729-96-2
PubChem CID443385
DTXSIDDTXSID1048677
FormulaC18H34ClN2O8PS
Mol. Weight505 g/mol
SMILESCCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl

Data Sources

Brief citations

Clindamycin phosphate (CAS 24729-96-2) https://chemicalindependence.com/chemical/24729-96-2/ PubChem: 443385. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/443385 FDA National Drug Code directory: CAS 24729-96-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 24729-96-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/